Legal 500
Log in or register
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR

© 2026 Legalease Ltd. All rights reserved

Registered company in England & Wales No. 02427356 VAT GB 321 5727 22

Registered address: 188 Fleet Street, London, EC4A 2AG

  • Legal 500 Trust Centre
  • Contact Us
  • home
  • Market Intelligence
  • Search

442 results found

Use advanced search filters to refine your search

2 filters applied

Advanced search filters

Topics
Countries
Contributor

Start typing to add contributors

Content type
Show options
  • Article

    Position Of Biologics /Biosimilars /Biogenerics Products In India

    When Stanley N. Cohen of Stanford and Herbert W. Boyer obtained a US patent in 1980 for the process for joining and replicating DNA from different species little they realized that they are ushering the era of Recombinant revolution for the entry of biologics as potential drugs or organic food products.
    IndiaFood, Drugs, Healthcare, Life Sciences
    Lex Orbis
    Lex Orbis
  • Article

    Bombay HC Dismisses Challenge To Nexavar Compulsory License

    The Bombay High Court dismissed a challenge by Bayer AG against a decision to allow Natco Pharma Ltd to manufacture and sell a generic copy of a patent-protected cancer drug.
    IndiaIntellectual Property
    S&A Law Offices
    S&A Law Offices
  • Article

    Ministry Of Environment, Forest And Climate Change Notifies Biological Diversity (Amendment) Rules, 2025; Streamlines Procedure For Obtaining Certificate Of Origin For Cultivated Medicinal Plants

    The Ministry of Environment, Forest and Climate Change ("MoEFCC") has notified the Biological Diversity (Amendment) Rules, 2025 ("Amendment"), effective from 1st November 2025.
    IndiaEnvironment
    Lexplosion Solutions Private Limited
    Lexplosion Solutions Private Limited
  • Video

    The Indian Medical Device Industry 23 October 2017 (Video)

    Nishith Desai Associates is a research-based Indian law firm with offices in Mumbai, Silicon Valley, Bangalore, Singapore, Mumbai BKC, Delhi and Munich that aims at providing strategic, legal and tax services...
    IndiaFood, Drugs, Healthcare, Life Sciences
    Nishith Desai Associates
    Nishith Desai Associates
  • Article

    Uncertainty Remains Over Scope Of Value Added Products And Biological Resources

    Rich and varied biodiversity, accompanied by an extensive traditional and contemporary knowledge system makes India one of the most diverse nations in the world in this regard.
    IndiaFood, Drugs, Healthcare, Life Sciences
    Lex Orbis
    Lex Orbis
  • Article

    Review Of Existing Policy For FDI In Pharma Sector

    According to Circular 1 of 2013, 100% FDI is allowed for green field and Brownfield projects under automatic route and the government approval route respectively.
    IndiaGovernment, Public Sector
    S&A Law Offices
    S&A Law Offices
  • Article

    Products Of Artificial Intelligence: Thinking Aloud Creativity And Innovation

    When Hitachi design a nose cone for the Japanese bullet train using AI which improved aerodynamic performance and reduced cabin noise levels
    IndiaTechnology
    Lex Orbis
    Lex Orbis
  • Article

    Checking The Pulse Recent Legal Developments In The Indian Healthcare And Pharma Sector

    In the past couple of months, the healthcare and pharmaceutical sector has witnessed a wave of regulatory and policy shifts, reflecting a clear push towards strengthening oversight, enhancing drug safety and streamlining compliance norms
    IndiaFood, Drugs, Healthcare, Life Sciences
    CMS INDUSLAW
    CMS INDUSLAW
  • Video

    A Landmark Judgment On Altruistic Organ Donation (Video)

    The Kerala High Court has set a precedent in the case of Uvais Muhammad K.C. & Another v. State of Kerala & Others, emphasizing that genuine altruistic...
    IndiaFood, Drugs, Healthcare, Life Sciences
    IndiaLaw LLP
    IndiaLaw LLP
  • Podcast

    Episode 1: Indian Pharmaceuticals Investing In Latin America (Podcast)

    In this episode we provide a vision of how does Latin America could be a potential market for Indian Pharmaceutical companies investments, the efforts the companies are doing and the insight of the Indian Government efforts to help this industry to invest in Latin America.
    IndiaFood, Drugs, Healthcare, Life Sciences
    Dentons
    Dentons
  • Article

    Pharmaceutical Trademarks In The Indian Perspective

    The Ministry of Health and Family Welfare and the Ministry of Chemicals and Fertilisers play a major role in regulating the healthcare and pharmaceutical sectors.
    IndiaIntellectual Property
    Lex Orbis
    Lex Orbis
  • Article

    Directions For Clinical Trial Application By CDSCO

    Drug Controller General of India directed all the Stakeholders involved in the conduct of Clinical Trial in the country to include following information in their Clinical Trial Application.
    IndiaFood, Drugs, Healthcare, Life Sciences
    S&A Law Offices
    S&A Law Offices
  • Article

    MSD Divests 6 Brands To Zydus Healthcare Limited

    United States pharmaceutical giant Merck & Co., Inc. (known as Merck Sharp & Dohme (MSD) outside the United States and Canada), through its subsidiaries, divested its 6 brands to Zydus Cadila's wholly owned subsidiary Zydus Healthcare Limited.
    IndiaFood, Drugs, Healthcare, Life Sciences
    Nishith Desai Associates
    Nishith Desai Associates
  • Article

    Food & Pharma Flash - December 2013

    The 100% FDI in pharma sector through automatic approval route in new projects and investments in the existing companies only through the approval route has prompted several acquisitions and not given the desired result.
    IndiaFood, Drugs, Healthcare, Life Sciences
    PSA
    PSA
  • Article

    Indian Government prohibits 328 fixed dose combinations

    The Ministry of Health and Family Welfare, Government of India vide Gazette notification nos. S.0.4379(E) to S.0.4706(E) dated 07.09.2018 has prohibited 328 Fixed Dose Combinations (FDCs) for manufacture, sale or distribution with immediate effect ..
    IndiaFood, Drugs, Healthcare, Life Sciences
    Lex Orbis
    Lex Orbis
  • Article

    Regulated Medical Devices In India To Lose Exemption From Labelling Requirements

    On June 23 2017, the Government of India notified an amendment to a law that regulates contents of labels of all pre-packaged goods sold in India.
    IndiaFood, Drugs, Healthcare, Life Sciences
    Nishith Desai Associates
    Nishith Desai Associates
  • Article

    Sun Pharma To Acquire Organon

    On April 26, 2026, Sun Pharmaceutical Industries Limited (“Sun Pharma”) and Organon & Co. (“Organon”) announced an agreement for Sun Pharma to acquire all outstanding shares of Organon...
    IndiaFood, Drugs, Healthcare, Life Sciences
    Goodwin Procter LLP
    Goodwin Procter LLP
  • Article

    IPO's Patent To Gilead's Sofobuvir (Sovaldi) Challenged At Delhi High Court

    A Writ Petition has been filed before the Delhi High Court, challenging the grant of patent for Gilead's megahit anti Hepatitis-C virus drug, sofobuvir which is known commercially everywhere as "Sovaldi".
    IndiaIntellectual Property
    H K Acharya & Co
    H K Acharya & Co
  • Article

    Take A Bow - Kibow!

    La Renon then approached the Madras High Court in an appeal against the IPAB order in the form of a writ petition.
    IndiaIntellectual Property
    R. K. Dewan & Co
    R. K. Dewan & Co
  • Article

    No Service Tax Payable On Services Provided By Cord Blood Banks And Services By Way Of Loading, Unloading, Warehousing Etc Of Rice

    Earlier the Central GOVERNMENT vide its notification exempted certain taxable services from the whole of the service tax leviable thereon under section 66B.
    IndiaTax
    S&A Law Offices
    S&A Law Offices
  • Showing 1–20 of 442 results

    Next
    Legal Intelligence Newsletters: sign up for the latest legal and regulatory news on your chosen topics